Search

everythinglearnresearchcommunity

for

Search:↓

Isotretinoin may cause temporary, reversible facial hair growth in some women.

A thorough initial check-up is essential before sperm banking to ensure the best chance of preserving good quality sperm.

Most women with excess hair growth had Polycystic Ovary Syndrome, and severity wasn't linked to hormone levels.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Obesity in the U.S. is largely influenced by diet and exercise, certain medications can improve heart procedures and hair growth, and major teaching hospitals have better patient outcomes.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Early treatment of Female Pattern Hair Loss is important to stop it from getting worse, and various treatments can help, especially in mild to moderate cases.

Shift work disrupts the body's natural clock, leading to health problems.

New information suggests that metformin might help more women with PCOS and infertility, not just those with glucose issues.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Some birth control pills increase young women's risk of blood clots more than others.

Moxibustion may help improve ovarian function by changing androgen levels.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Female-pattern baldness is not linked to more migraines.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The case showed the need for quick investigation of virilization in women and how emotional health is linked to physical health.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

High androgen levels and genetic factors likely cause Becker's nevus and related symptoms.

Low-dose finasteride may cause fertility issues, but stopping it can improve sperm quality and lead to pregnancy.

Lifestyle changes and medical treatment can help manage PCOS symptoms in young adults.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

AMH is a good marker for diagnosing PCOS, but global standards are needed.